Furthermore, these cells interacted with tumor cells via TGF-β and NOTCH signaling pathways, contributing to ECM remodeling, while also suppressing immune responses through the PVR-TIGIT signaling axis. The gene discussed is TIGIT; the disease is neoplasm.